Chronic vasodilation induces matrix metalloproteinase 9 (MMP-9) expression during micro vascular remodeling in rat skeletal muscle

Microcirculation

Volumn 8, Issue 1, 2001, Pages 25-31

  Van Gieson, Eric J ^a   Skalak, Thomas C ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Matrix, prazosin; Remodeling; Vascular growth

Indexed keywords

ANIMALIA;

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; GELATINASE B; PRAZOSIN;

ANGIOGENESIS; ANIMAL; ARTICLE; CAPILLARY; DRUG EFFECT; ENZYMOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; HISTOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; VASCULARIZATION; VASODILATATION; WESTERN BLOTTING;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; CAPILLARIES; FEMALE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICROCIRCULATION; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0035259148     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7300147     Document Type: Article

References (30)

1. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B. (1997). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3 [see comments]. Invest Ophthalmol Vis Sci 38:817-823.
2. Birkedal-Hansen H. (1995). Proteolytic remodeling of extracellular matrix. Curr Opiri Cell Biol 7:728-735.
3. Cornelius LA, Nehririg LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Steven D, Shapiro SD. (1998). Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 161:6845-6852.
4. Cowan KN, Jones PL, Rabinovitch M. (1999). Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 84:1223-1233.
5. Das A, McLamore A, Song WM, McCuire PG. (1999). Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthalmol 117:498-503.
6. Dawson JM, Hudlicka O. (1989). The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23:913-920.
7. Engelson ET, Skalak TC, Schmid-Schönbein GW. (1985). The microvasculature in skeletal muscle. I. Arteriolar network in rat spinotrapezius muscle. Microvasc Res 30:29-44.
8. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. (1998). Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-377.
9. Hirschi KK, Rohovsky SA, D'Amore PA. (1998). PDGF, TGF-beta, arid heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. [Published erratum appears in J Cell Biol (1998) 141(5):1287.] J Cell Biol 141:805-814.
10. Hudlicka O. (1998). Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5:5-23.
11. Hudlicka O, Brown M, Egginton S. (1992). Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72:369-417.
12. Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194-202.
13. Ju HS, Hao JM, Zhao SK, Dixon IMC. (1998). Antiproliferative and antifibrotic effects of mimosine on adult cardiac fibroblasts. Biochim Biophys Acta 1448:51-60.
14. Kenagy RD, Hart CE, Stetler-Stevenson WG, Clowes AW. (1997). Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9. Circulation 96:3555-3560.
15. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M, Alameddine HS. (1999). Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205:158-170.
16. Lijnen HR, Ugwu F, Bini A, Collen D. (1998). Gerieration of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37: 4699-4702.
17. Mason DP, Kenagy RD, Hasenstab D, Bowen-Pope DF, Seifert RA, Coats S, Hawkins SM, Clowes AW. (1999). Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 85:1179-1185.
18. Moses MA, Langer R. (1991). A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 47:230-235.
19. Nicosia RF, Villaschi S. (1995). Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 73:658-666.
20. Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Dano K, Coy DL, Srivastava A, Gottstein J, Butterworth RF, Blei AT. (1997). Expression of matrix metalloproteinase-9 in vascular pericytes in human breast cancer. Lab Invest 77:345-355.
21. Patterson BC, Sang QXA. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B type IV collagenase (MMP-9). J Biol Chem 272:28823-28825.
22. Price RJ, Skalak TC. (1994). Circumferential wall stress as a mechanism for arteriolar rarefaction and proliferation in a network model. Microvasc Res 47: 188-202.
23. Price RJ, Skalak TC (1996). Chronic alpha 1-adrenergic blockade stimulates terminal and arcade arteriolar development. Am J Physiol 271:H752-H759.
24. Price RJ, Skalak TC. (1998). Prazosin administration enhances proliferation of arteriolar adventitial fibroblasts. Microvasc Res 55:138-145.
25. Romanic AM, Madri JA. (1994). The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J Cell Biol 125: 1165-1178.
26. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. (1998). Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020-1030.
27. Tetlow LC, Lees M, Ogata Y, Nagase H, Woolley DE. (1993). Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid syno vial cells in vitro and in vivo. Rheumatol Int 13:53-59.
28. Werb Z, Vu TH, Rinkenberger JL, Coussens LM. (1999). Matrix-degrading proteases and angiogenesis during development and tumor formation [Review]. APMIS 107:11-18.
29. Zhou A, Egginton S, Hudlicka O, Brown MD. (1998). Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with alpha1-antagonist prazosin. Cell Tissue Res 293:293-303.
30. Zhou AL, Egginton S, Brown MD, Hudlicka O. (1998). Capillary growth in overloaded, hypertrophic adult rat skeletal muscle - an ultrastructural study. Anat Rec 252:49-63.